Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HPS-328 transdermal bisoprolol patch versus oral Emcor in healthy male volunteers
NL-OMON36691Active, not recruiting
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of HPS-328 and Emcor in hypertension (HTN) and angina pectoris, sponsored by Hisamitsu Pharmaceutical Co., Inc. Started Jan 2011; status: active, not recruiting.
02
Drugs
HPS-328Emcor
03
Conditions
hypertension (HTN)angina pectoris
Beyond the preview
Go deeper on NL-OMON36691.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36691.